{
  "retracted": false,
  "timestamp": 1570233600000,
  "updates": [
    {
      "timestamp": 1591663582302,
      "identifier": {
        "doi": "10.1007/s00280-019-03964-6"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00280-019-03820-7"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial"
}
